Max Planck Institute for Molecular Biomedicine
Max-Planck-Institut für molekulare Biomedizin
Germany
1 August 2017 - 31 July 2018
Principal institution: Max Planck Society
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Max Planck Institute for Molecular Biomedicine published between 1 August 2017 - 31 July 2018 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| AC | FC |
|---|---|
| 25 | 4.85 |
Outputs by subject (FC)
| Subject | AC | FC | |
|---|---|---|---|
| Life Sciences | 22 | 4.29 | |
| Chemistry | 2 | 0.45 | |
Top articles by Altmetric score in current window
The Gcn4 transcription factor reduces protein synthesis capacity and extends yeast lifespan
Nature Communications
2017-09-06
BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions
Science Translational Medicine
2017-12-06
A molecular roadmap for the emergence of early-embryonic-like cells in culture
Nature Genetics
2017-12-18
Nfat/calcineurin signaling promotes oligodendrocyte differentiation and myelination by transcription factor network tuning
Nature Communications
2018-03-02
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
